Additional information
Percentage | 20% |
---|---|
Target Formulations | Injectables |
Routes of administration | Intravenous, Topical |
Documentation Available: | Technical Package |
There might be certain missing updates on recent developments and advances. Please send an email to marketing@mkppl.com or info@mkppl.com for updated information.